2020
A Multicenter VA Study of the Format and Content of Internal Medicine Morning Report
Heppe DB, Beard AS, Cornia PB, Albert TJ, Lankarani-Fard A, Bradley JM, Guidry MM, Kwan B, Jagannath A, Tuck M, Fletcher KE, Gromisch ES, Gunderson CG. A Multicenter VA Study of the Format and Content of Internal Medicine Morning Report. Journal Of General Internal Medicine 2020, 35: 3591-3596. PMID: 32779143, PMCID: PMC7728907, DOI: 10.1007/s11606-020-06069-6.Peer-Reviewed Original ResearchConceptsMorning reportPresentation slidesEvidence-based medicineRange of learnersHigh-value careTypes of learnersChief residentsSocial determinantsInternal medicine residency programsMedication side effectsLearner participationCase-based reportsTeaching presentationBedside teachingEducational activitiesContent areasSingle caseMedical studentsLife-threatening diseaseAcademic medical centerMedicine residency programsLearnersResident educationResultsA totalUltimate diagnosis
2017
Setting Performance Standards for a Cost-Effective Human Immunodeficiency Virus Cure Strategy in South Africa
Paltiel AD, Zheng A, Weinstein MC, Gaynes MR, Wood R, Freedberg KA, Sax PE, Walensky RP. Setting Performance Standards for a Cost-Effective Human Immunodeficiency Virus Cure Strategy in South Africa. Open Forum Infectious Diseases 2017, 4: ofx081. PMID: 28680903, PMCID: PMC5490502, DOI: 10.1093/ofid/ofx081.Peer-Reviewed Original ResearchHIV cure strategiesCure strategiesHuman immunodeficiency virus (HIV) eradicationLifetime antiretroviral therapySustained viral eradicationElimination of HIVStandard of careLifetime costsAntiretroviral therapyViral eradicationHIV cureFatal toxicitySingle interventionVirus eradicationLife expectancyCureLower lifetime costsSingle caseSurvival
2005
N-acetylcysteine augmentation in serotonin reuptake inhibitor refractory obsessive-compulsive disorder
Lafleur DL, Pittenger C, Kelmendi B, Gardner T, Wasylink S, Malison RT, Sanacora G, Krystal JH, Coric V. N-acetylcysteine augmentation in serotonin reuptake inhibitor refractory obsessive-compulsive disorder. Psychopharmacology 2005, 184: 254-256. PMID: 16374600, DOI: 10.1007/s00213-005-0246-6.Peer-Reviewed Original ResearchConceptsRefractory obsessive-compulsive disorderObsessive-compulsive disorderN-acetylcysteineGlutamatergic neurotransmissionUse of NACYale-Brown Obsessive Compulsive Scale scoresSerotonin reuptake inhibitorsEfficacy of augmentationRecent clinical reportsTreatment of OCDCompulsive Scale scoresNAC augmentationGlutamatergic dysfunctionReuptake inhibitorsLabel usePsychiatric disordersClinical reportsScale scoreModulating agentsDisordersSingle casePatientsFluvoxamineNeurotransmissionOCD symptoms
1996
Myosin VIIA mutation screening in 189 Usher syndrome type 1 patients.
Weston M, Kelley P, Overbeck L, Wagenaar M, Orten D, Hasson T, Chen Z, Corey D, Mooseker M, Sumegi J, Cremers C, Moller C, Jacobson S, Gorin M, Kimberling W. Myosin VIIA mutation screening in 189 Usher syndrome type 1 patients. American Journal Of Human Genetics 1996, 59: 1074-83. PMID: 8900236, PMCID: PMC1914835.Peer-Reviewed Original ResearchConceptsCongenital profound hearing lossMyosin-VIIa mutationsType 1 patientsProfound hearing lossUsher syndrome type 1BUnique mutationsPresence of mutationsAutosomal recessive disorderVestibular abnormalitiesMyosin VIIA geneHearing lossRetinitis pigmentosaPatientsType 1bI casesRecessive disorderSingle caseCompound heterozygotesPremature stop codonSimple heterozygotesGreater percentageUnrelated control samplesDisordersMutant allelesCurrent study
1990
The risk of transmission of HIV-1 through non-percutaneous, non-sexual modes—a review
Gershon R, Vlahov D, Nelson K. The risk of transmission of HIV-1 through non-percutaneous, non-sexual modes—a review. AIDS 1990, 4: 645-650. PMID: 2204358, DOI: 10.1097/00002030-199007000-00006.Peer-Reviewed Original Research
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply